Fulcrum Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +1,076.4% | +117.2% | -66.9% | -55.8% | +2,752.0% | -100.0% | |
| – | +88.1% | +52.6% | +15.9% | +5.7% | +2,953.0% | -6.5% | -11.7% | -97.8% | |
| – | – | – | – | +117.2% | -467.6% | – | – | -108.4% | |
| – | +36.2% | +182.2% | -16.9% | +18.1% | +10.2% | -6.5% | -11.7% | -11.5% | |
| – | +84.8% | +58.1% | +62.7% | +42.7% | +36.6% | -6.1% | -10.7% | -18.0% | |
| – | +45.7% | +151.4% | -4.5% | +24.6% | -58.0% | -1.1% | -7.6% | +116.5% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -1.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | -491.6% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.